Brought to you by 
QLT to loan up to $9.9mm to InSite in connection with acquisition; withdrawn
17 Sep 2015
Executive Summary
InSite Vision Inc. (marketed products and drug candidates in ophthalmology) could receive up to $9.9mm via a secured line of credit from QLT Inc., which concurrently acquired InSite in a stock deal worth $21.1mm.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
- Topical Delivery
-
Drug Delivery
Deal Status
- Withdrawn
Deal Type
-
Financing
- Nonconvertible Debt
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
QLT to loan up to $9.9mm to InSite in connection with acquisition; withdrawn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice